| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.067 | 0.4 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.4 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.4 |